Fernando F. Blanco, Ph.D.
Affiliations: | 2012 | Biomedical Science | University of South Carolina, Columbia, SC |
Area:
Oncology, Molecular Biology, BiochemistryGoogle:
"Fernando Blanco"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Dan A. Dixon | grad student | 2012 | University of South Carolina | |
| (The Regulation of ARE-Mediated mRNA Decay During Colorectal Tumorigenesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Blanco FF, Preet R, Aguado A, et al. (2016) Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis. Oncotarget |
| Zhou H, Telonis AG, Jing Y, et al. (2016) GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR. Cell Death & Disease. 7: e2294 |
| Zhou H, Telonis A, Jing Y, et al. (2016) Abstract A41: GPRC5A acts as a potent oncogene in pancreatic cancer Cancer Research. 76 |
| Blanco FF, Jimbo M, Wulfkuhle J, et al. (2015) The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells. Oncogene |
| Sobolewski C, Sanduja S, Blanco FF, et al. (2015) Histone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells. Biomolecules. 5: 2035-55 |
| Jimbo M, Blanco FF, Huang YH, et al. (2015) Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells. Oncotarget |
| Piasecka-Srader J, Blanco FF, Delman DH, et al. (2015) Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries. Biology of Reproduction. 92: 132 |
| Cozzitorto JA, Jimbo M, Chand S, et al. (2015) Studying RNA-binding protein interactions with target mRNAs in eukaryotic cells: native ribonucleoprotein immunoprecipitation (RIP) assays. Methods in Molecular Biology (Clifton, N.J.). 1262: 239-46 |
| Tholey RM, Lal S, Jimbo M, et al. (2015) MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer. Molecular Cancer Research : McR. 13: 439-48 |
| Jimbo M, Blanco FF, Huang YH, et al. (2015) Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells Oncotarget. 6: 27312-27331 |